Vol. 31 (3) 2024 – 12

Interleukin-10 as a marker for response to dendritic cells-dribbles immunotherapy in hepatocellular carcinoma, a mice model….. Original Research Article….. The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 31 (3), July, 2024 Pages: 123–130....

Vol. 31 (3) 2024 – 11

Assessment of the impact of cytomegalovirus seropositivity on blood parameters in renal hemodialysis patients….. Original Research Article….. The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 31 (3), July, 2024 Pages: 113–122....

Vol. 31 (3) 2024 – 10.1

Immunogenicity study of a Novel DNA-Based HCV vaccine candidate….. Supplementary Data ….. The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 31 (3), July, 2024 Pages: 01–09. www.Ejimmunology.org https://doi.org/10.55133/eji.310310 Eman A. Salem1,...

Vol. 31 (3) 2024 – 10

Immunogenicity study of a Novel DNA-Based HCV vaccine candidate….. Original Research Article….. The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 31 (3), July, 2024 Pages: 95–112. www.Ejimmunology.org https://doi.org/10.55133/eji.310310 Eman A....

Vol. 31 (3) 2024 – 09

Serum calgranulin C as a non-invasive predictor of activity among inflammatory bowel disease….. Original Research Article….. The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 31 (3), July, 2024 Pages: 81–94. www.Ejimmunology.org...

Vol. 31 (3) 2024 – 08

Investigate role of miRNA146a and IL-17 level in progressive rheumatoid arthritis disease….. Original Research Article….. The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 31 (3), July, 2024 Pages: 71–80. www.Ejimmunology.org...